Christensen will "continue to provide consultative support to the company on partner interactions, licensing and other business activities," DiaGenic said in a statement.

Henrik Lund, chairman of the company's board, will serve as CEO until a replacement for Christensen is found. Ingrid Wiik, deputy chairman of the board, will act as chairman until the company's annual general meeting on June 5.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.